Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 53

Sort by

Sort Order Select

Journal Articles

An Observational Study of the Prescribing Practices and Patient Reported Outcomes Measures in Older People with Myelodysplastic Syndrome

Angela Molga, MBBS, Michelle Wall, Dip HE (Nursing), BA (Hons), MSc, PG Cert, Rakchha Chhetri, MBBS, Amilia Wee, BSc (Hons), Deepak Singhal, MBBS, MDFRACP, FRCPA, Pratyush Giri, MBBS,FRACP,FRCPA, Timothy To, BSc, BMBS, FRACP, FAChPM, Devendra K Hiwase, MBBS, MD FRACP, FRCPA, PhD

Blood (2019) 134 (Supplement_1): 5426.

https://doi.org/10.1182/blood-2019-132164

Published: 2019

Journal Articles

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Emelie Curovic Rotbain, MD, Carsten Utoft Niemann, MD PhD Ass. Prof, Klaus Rostgaard, MSc., Caspar Da Cunha-Bang, MD PhD, Henrik Hjalgrim, MD Dr.MD, Henrik Frederiksen, MD Prof

Blood (2019) 134 (Supplement_1): 4285.

https://doi.org/10.1182/blood-2019-122673

Published: 2019

Journal Articles

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Jordon Jaggers, Heidi D. Klepin, MD, Tanya M. Wildes, MD, Rebecca L. Olin, MD, Andrew S. Artz, MD, Sarah A Wall, MD, Samantha Jaglowski, MDMPH, Basem M. William, MRCP,MD, Don M. Benson, Jr., MD PhD, Ashley E. Rosko, MD

Blood (2019) 134 (Supplement_1): 5819.

https://doi.org/10.1182/blood-2019-131504

Published: 2019

Journal Articles

Predictors of the Rowland Universal Dementia Assessment Scale (RUDAS) Performance in Adults with Sickle Cell Disease

Stéphanie Forté, MD MSc, FRCPC, Florence Blais, Mathias Castonguay, Nafanta Fadiga, Richard Ward, MSc, MRCP, FRCPath, Béland Sébastien, PhD, Melanie Cohn, PhD CPsych, Denis Soulières, MD, Kevin H. M. Kuo, MDMSc,FRCPC

Blood (2019) 134 (Supplement_1): 2294.

https://doi.org/10.1182/blood-2019-129342

Published: 2019

Journal Articles

Updated Results of a Phase II Study of Reduced-Intensity Chemotherapy with Mini-Hyper-CVD in Combination with Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Blood (2019) 134 (Supplement_1): 823.

https://doi.org/10.1182/blood-2019-125136

Published: 2019

Journal Articles

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Annie Lacerte, MD PhD, Marie-Pier Bleau, MD, Jean-Francois Castilloux, MD, Flavia De-angelis, MD, Pierre Desjardins, MD, Michel Pavic, MD, Tamas Fulop, MD PhD

Blood (2018) 132 (Supplement 1): 4213.

https://doi.org/10.1182/blood-2018-99-117640

Published: 2018

Journal Articles

Evaluation of a Standardized Geriatric Assessment at Diagnosis in a Prospective Cohort of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Colombe Saillard, MD, Frederique Rousseau, Maud Cecile, Cecile Braticevic, Anne Etienne, Jerome Rey, Evelyne D'Incan, Christophe Zemmour, Norbert Vey, MD PhD, Aude Charbonnier

Blood (2018) 132 (Supplement 1): 2671.

https://doi.org/10.1182/blood-2018-99-116400

Published: 2018

Journal Articles

Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study

Blood (2018) 132 (Supplement 1): 36.

https://doi.org/10.1182/blood-2018-99-114955

Published: 2018

Journal Articles

Impact of Intended and Relative Dose Intensity of RCHOP in a Large, Consecutive Cohort of Elderly DLBCL Patients: No Difference in DFS for 70-80 Years Versus >80 Years and Idi Independently Predicts Survival

Toby A. Eyre, Nicolas Martinez-Calle, MD, Catherine Hildyard, David W. Eyre, Hannah Plaschkes, Jonathan Griffith, Julia Wolf, Chris P Fox, Andrew McMillan, Mark Bishton, Graham P. Collins, MB BS DPhil, Chris Hatton, MD

Blood (2018) 132 (Supplement 1): 573.

https://doi.org/10.1182/blood-2018-99-110330

Published: 2018

Journal Articles

Prognostic Implications of Specific Comorbidities in Mantle Cell Lymphoma Patients, a Swedish Lymphoma Registry Study

Ingrid Glimelius, MD PhD, Karin Ekstroem Smedby, MD PhD, Mats Jerkeman, Sandra Eloranta, Caroline Weibull

Blood (2018) 132 (Supplement 1): 2891.

https://doi.org/10.1182/blood-2018-99-111471

Published: 2018

Journal Articles

Association of Sickle Cell Trait with Measures of Cognitive Function and Dementia in African Americans

Chen Nemin, BS, Christina Caruso, MD, Alvaro Alonso, MD PhD, Vimal K. Derebail, MD, Abhijit V Kshirsagar, MD, Richey Sharrett, MD DrPH, Nigel S. Key, MBChB, FRCP, Rebecca Gottesman, MD PhD, Megan Grove, MS, Jan Bressler, PhD, Eric Boerwinkle, PhD, B. Gwen Windham, MD MHS, Thomas H Mosley, Jr., PhD, Hyacinth I Hyacinth, MDPhDMPH

Blood (2018) 132 (Supplement 1): 1099.

https://doi.org/10.1182/blood-2018-99-109832

Published: 2018

Journal Articles

Prevalence of Folic Acid Deficiency and Cost Effectiveness of Folic Acid Testing: A Single Center Experience

Karina Diaz, Zhu Na, Sorab Gupta, MD, Vikram Arya, Lourdes Martinez, Supreet Dhaliwal, Nora Ajdir, Bhavita Gaglani, Shradha Ahuja, MD, Ilmana Fulger, MD

Blood (2018) 132 (Supplement 1): 4878.

https://doi.org/10.1182/blood-2018-99-111607

Published: 2018

Journal Articles

Adherence to Lenalidomide in Older Patients with Multiple Myeloma (MM): A SEER-Medicare Analysis

Tanya Wildes, MD, Mark A. Fiala, BS, Ravi Vij, MDMBA

Blood (2017) 130 (Supplement 1): 3432.

https://doi.org/10.1182/blood.V130.Suppl_1.3432.3432

Published: 2017

Journal Articles

A Phase I/II Study of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Blood (2017) 130 (Supplement 1): 2576.

https://doi.org/10.1182/blood.V130.Suppl_1.2576.2576

Published: 2017

Journal Articles

Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia

Adam J Olszewski, MD, Pamela C Egan, MD, Thomas W. LeBlanc, MD MA

Blood (2017) 130 (Supplement 1): 277.

https://doi.org/10.1182/blood.V130.Suppl_1.277.277

Published: 2017

Journal Articles

Major Bleeding and Bleeding Events Requiring Hospitalization in the First Three Months Following Vitamin K Antagonists Therapy in Patients with First Venous Thromboembolism

Carlos Martinez, MD MSc, Alexander Cohen, MD, Anja Katholing, MSc, Christopher Wallenhorst, MSc, Xiaoyan Li, PhD, Gail Wygant, RN

Blood (2017) 130 (Supplement 1): 2076.

https://doi.org/10.1182/blood.V130.Suppl_1.2076.2076

Published: 2017

Journal Articles

Towards Stratification of Lymphomas with Involvement of the Central Nervous System Using miRNA-Seq from Small Volumes of Cerebrospinal Fluid

Sarah Grasedieck, MSc, Medhanie A. Mulaw, Jun.-Prof. Dr., Christina Miller, Arefeh Rouhi, PhD, Jeanette K Doorduijn, MD PhD, Jacoline E. Bromberg, MD, Florian Kuchenbauer, Daniel Mertens, PhD

Blood (2016) 128 (22): 1751.

https://doi.org/10.1182/blood.V128.22.1751.1751

Published: 2016

Journal Articles

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Frontline Therapy for Older Patients with Acute Lymphoblastic Leukemia (ALL): Interim Result of a Phase II Clinical Trial

Koji Sasaki, MD, Elias J. Jabbour, MD, Susan M. O'Brien, MD, Farhad Ravandi, MD, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Naval Daver, MD, Gautam Borthakur, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Nicholas J. Short, MD, Naveen Pemmaraju, MD, Yesid Alvarado, MD, Jovitta Jacob, RN, Rebecca Garris, MS, Philip A Thompson, MBBS, Jorge E. Cortes, MD, Hagop M. Kantarjian, MD

Blood (2016) 128 (22): 588.

https://doi.org/10.1182/blood.V128.22.588.588

Published: 2016

Journal Articles

The Utility of the Charlson Comorbidity Index in Predicting Use of Treatment and Survival in Older Lymphoma Patients

Gunjan L. Shah, MD MS, Aaron Winn, MPP, Anita J Kumar, MD MS, Miguel-Angel Perales, MD, Pei-Jung Lin, Ph DMS, Susan K Parsons, MD MRP

Blood (2016) 128 (22): 2405.

https://doi.org/10.1182/blood.V128.22.2405.2405

Published: 2016

Journal Articles

the Charlson Comorbidity Index Predicts Survival Following Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients

Osamu Imataki, Shumpei Uchida, Maki Oku, Shigeyuki Yokokura, Makiko Uemura, Norimitsu Kadowaki, MD PhD

Blood (2015) 126 (23): 5146.

https://doi.org/10.1182/blood.V126.23.5146.5146

Published: 2015

NARROW

An Observational Study of the Prescribing Practices and Patient Reported Outcomes Measures in Older People with Myelodysplastic Syndrome

Mapping Comorbidity in CLL: Impact on Prognostic Factors, Treatment Patterns and Causes of Death

Characterizing Inclusion and Exclusion Criteria in Clinical Trials for CAR-T Cellular Therapy Among Adults with Hematologic Malignancies

Predictors of the Rowland Universal Dementia Assessment Scale (RUDAS) Performance in Adults with Sickle Cell Disease

Updated Results of a Phase II Study of Reduced-Intensity Chemotherapy with Mini-Hyper-CVD in Combination with Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Adults with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Management of Diffuse Large B Cell Lymphoma in the Oldest Old—Insight into the Management Decision Process: A Canadian Perspective

Evaluation of a Standardized Geriatric Assessment at Diagnosis in a Prospective Cohort of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Chemoimmunotherapy with Inotuzumab Ozogamicin Combined with Mini-Hyper-CVD, with or without Blinatumomab, for Newly Diagnosed Older Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: Results from a Phase II Study

Impact of Intended and Relative Dose Intensity of RCHOP in a Large, Consecutive Cohort of Elderly DLBCL Patients: No Difference in DFS for 70-80 Years Versus >80 Years and Idi Independently Predicts Survival

Prognostic Implications of Specific Comorbidities in Mantle Cell Lymphoma Patients, a Swedish Lymphoma Registry Study

Association of Sickle Cell Trait with Measures of Cognitive Function and Dementia in African Americans

Prevalence of Folic Acid Deficiency and Cost Effectiveness of Folic Acid Testing: A Single Center Experience

Adherence to Lenalidomide in Older Patients with Multiple Myeloma (MM): A SEER-Medicare Analysis

A Phase I/II Study of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia

Transfusion Dependence and Use of Hospice Among Medicare Beneficiaries with Leukemia

Major Bleeding and Bleeding Events Requiring Hospitalization in the First Three Months Following Vitamin K Antagonists Therapy in Patients with First Venous Thromboembolism

Towards Stratification of Lymphomas with Involvement of the Central Nervous System Using miRNA-Seq from Small Volumes of Cerebrospinal Fluid

Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Frontline Therapy for Older Patients with Acute Lymphoblastic Leukemia (ALL): Interim Result of a Phase II Clinical Trial

The Utility of the Charlson Comorbidity Index in Predicting Use of Treatment and Survival in Older Lymphoma Patients

the Charlson Comorbidity Index Predicts Survival Following Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only